A polymorphism in the serotonin transporter (SERT) gene has been linked to increased susceptibility to PAH, although this polymorphism alone does not appear sufficient to mediate PAH. Emerging ...
Hosted on MSN11mon
EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient ComplianceIn February, Adial Pharmaceuticals received a U.S. patent covering AD04 and its ability to target the serotonin transporter gene for the potential treatment of opioid use disorder. The company ...
The treatment approach involves detecting the TT genotype of rs1042173 in the serotonin transporter gene (SLC6A4) and administering AD04. These treatment methods are tailored for individuals ...
A polymorphism in the serotonin transporter (SERT) gene has been linked to increased susceptibility to PAH, although this polymorphism alone does not appear sufficient to mediate PAH. Emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback